This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Johnson & Johnson secures damages in sale of Indian counterfeits to US

By Freny Patel ( March 13, 2025, 00:23 GMT | Insight) -- Johnson & Johnson has secured a significant victory in a trademark infringement lawsuit in India. The Delhi High Court awarded damages to the US multinational after counterfeit surgical devices, produced in India, were discovered being sold in the US. Delhi High Court Judge Amit Bansal emphasized the gravity of the offense, saying: “Counterfeiting of medical devices is not merely a case of trademark infringement, it is a grave offence that endangers the lives of people.”Johnson & Johnson, or J&J, has secured a significant victory in a trademark infringement lawsuit in India. The Delhi High Court awarded damages to the US multinational after counterfeit surgical devices, produced in India, were discovered being sold in the US....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections